These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 4542343

  • 41. The cryopreservation of immunocompetent cells.
    Grant CK, Powles R.
    Cryobiology; 1973 Sep; 10(4):290-4. PubMed ID: 4542998
    [No Abstract] [Full Text] [Related]

  • 42. Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity.
    Robins RA, Baldwin RW.
    Int J Cancer; 1974 Nov 15; 14(5):589-97. PubMed ID: 4376528
    [No Abstract] [Full Text] [Related]

  • 43. Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.
    Vose BM, Vánky F, Klein E.
    Int J Cancer; 1977 Dec 15; 20(6):895-902. PubMed ID: 591128
    [Abstract] [Full Text] [Related]

  • 44. Kinetics and characterization of antigen-binding and antibody-producing cells in the regional draining lymph nodes and spleen during initial murine schistosomiasis. I. Cellular responses against cercarial immunogens.
    Khoury PB, Lloyd SS, Reid WA, Weiner DJ, Phillips SM, Soulsby EJ.
    Cell Immunol; 1981 Apr 15; 59(2):233-45. PubMed ID: 6974599
    [No Abstract] [Full Text] [Related]

  • 45. Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma.
    Ortiz de Landazuri M, Kedar E, Fahey JL.
    J Natl Cancer Inst; 1974 Jan 15; 52(1):147-52. PubMed ID: 4204244
    [No Abstract] [Full Text] [Related]

  • 46. Response of T and B lymphocytes in the spleen, lymph nodes and mammary tumors in rats treated with human soluble tumor-associated antigens and commercial human albumin.
    Ben-Hur H, Kossoy G, Mehrdad H, Elhayany A, Zusman I.
    Oncol Rep; 2004 Dec 15; 12(6):1329-33. PubMed ID: 15547759
    [Abstract] [Full Text] [Related]

  • 47. Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction.
    Nussenzweig MC, Steinman RM.
    J Exp Med; 1980 May 01; 151(5):1196-212. PubMed ID: 6445399
    [Abstract] [Full Text] [Related]

  • 48. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ, Kataoka T, Hanna MG.
    Cancer Res; 1976 Dec 01; 36(12):4459-66. PubMed ID: 187324
    [Abstract] [Full Text] [Related]

  • 49. Lymphocyte-mediated cytotoxicity against tumor cells. III Differentiation of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD, Waterfield EM.
    Eur J Immunol; 1976 May 01; 6(5):317-20. PubMed ID: 136357
    [Abstract] [Full Text] [Related]

  • 50. A high frequency of cytotoxic precursor cells for a syngeneic tumour.
    Warren HS, Lafferty KJ.
    Scand J Immunol; 1979 May 01; 10(4):349-52. PubMed ID: 119310
    [Abstract] [Full Text] [Related]

  • 51. Immunostimulation of highly immunogenic target tumor cells by lymphoid cells in vitro.
    Prehn LM.
    J Natl Cancer Inst; 1976 Apr 01; 56(4):833-8. PubMed ID: 1255801
    [Abstract] [Full Text] [Related]

  • 52. Proceedings: Separation of subpopulations of rat lymph node cells cytotoxic for tumour target cells and capable of inhibiting cytotoxicity in vitro.
    Rees RC, Bray J.
    Br J Cancer; 1975 Aug 01; 32(2):240. PubMed ID: 1240006
    [No Abstract] [Full Text] [Related]

  • 53. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
    Laliotou B, Duncan L, Dick AD.
    J Autoimmun; 1999 May 01; 12(3):145-55. PubMed ID: 10222024
    [Abstract] [Full Text] [Related]

  • 54. Gross-virus-induced lymphoma in the rat. IV. Cytotoxic cells in normal rats.
    Shellam GR, Hogg N.
    Int J Cancer; 1977 Feb 15; 19(2):212-24. PubMed ID: 838521
    [Abstract] [Full Text] [Related]

  • 55. Immunologic reactivity of lymph nodes regional to prostatic cancer: preliminary observations.
    Herr HW.
    J Surg Oncol; 1977 Feb 15; 9(5):509-16. PubMed ID: 304125
    [Abstract] [Full Text] [Related]

  • 56. In vivo regulation of the cytolytic T cell response to hapten-altered self: suppressor T cells induced in the regional lymph nodes by exposure to syngeneic spleen cells.
    Wong HL, Battisto JR.
    Eur J Immunol; 1984 Jul 15; 14(7):629-33. PubMed ID: 6235115
    [Abstract] [Full Text] [Related]

  • 57. Significance of serum factors modifying cellular immune responses to growing tumours.
    Baldwin RW, Price MR, Robins RA.
    Br J Cancer Suppl; 1973 Aug 15; 1():37-47. PubMed ID: 4374231
    [Abstract] [Full Text] [Related]

  • 58. Reactivity of tumor-infiltrating, blood, spleen and lymph node lymphocytes against syngeneic glioma target cells.
    Stavrou D, Bilzer T, Anzil AP, Hultén M, Kaldrymidou E.
    Anticancer Res; 1981 Aug 15; 1(3):125-34. PubMed ID: 7342850
    [Abstract] [Full Text] [Related]

  • 59. The immunopharmacology of head and neck cancer: an update.
    Hadden JW.
    Int J Immunopharmacol; 1997 Aug 15; 19(11-12):629-44. PubMed ID: 9669203
    [Abstract] [Full Text] [Related]

  • 60. The lymphocyte in immunobiology.
    Ritzmann SE, Daniels JC, Sakai H, Beathard GA.
    Ann Allergy; 1973 Mar 15; 31(3):109-25. PubMed ID: 4569670
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.